#Vineti's Chief Operating Officer, Louise Pacini, speaking at the 5th Gene Therapy for Rare Disorders in Boston! In her presentation, Louise laid out the challenges faced by healthcare providers working with gene therapies & the many solutions to address these issues. #GTxRD2022
Vineti welcomes Ann Klein as our new CEO! Ann brings more than 25 years of healthcare technology leadership as Vineti scales its Personalized Therapy Management® (PTM) platform and transitions into its next phase of growth.
Senior VP of Business Development at #Vineti, @marcpu, will be attending this year's @Phacilitate#AdvancedTherapiesWeek! If you're heading down to Miami to connect with leaders making their mark on #advancedtherapies, schedule a time to meet with Marc: https://t.co/8we3RjNGDa
Chief Commercial Officer of #Vineti, Joe DePinto, will be moderating a discussion on #cellandgenetherapy market updates at this year's @VBCancerCare summit, Oct. 14th.
To view panelists & register for this event, visit: https://t.co/yfIjAuXe83
#Celltherapy#genetherapy news! As #CGMesa21 kicks off later today, we’ve very excited to announce our new partnership with @KoerberPharma to integrate with Werum PAS-X MES. Our shared goal -- help scale transformative therapeutics. @alliancerm https://t.co/nfkhLtd6r5
Don't miss our upcoming discussion on Oct. 7 where #Vineti experts will touch on how our PTM® platform can help support clinical studies using digital technology to streamline the cell & gene therapy supply chain.
Space is limited so register today: https://t.co/4zIDn8OnSt
#ICYMI: we ran a live virtual event to talk about progress with our allogeneic #celltherapy platform, inc. our intent to file an IND for our 1st allo TCR against MAGE‑A4 in late 2023 & the strategic collaboration w/ @Genentech. Click below to access the replay of the live event.
The need for solutions that simplify & scale advanced therapy studies is urgent. Experts from the cell and gene therapy ecosystem recently collaborated to share proven solutions for clinical scale – read the highlights here: https://t.co/u26JeAUy2S
#CellTherapy#GeneTherapy
#ICYMI: With PTM Essentials™, our goal is to help scale Imvax’s lead program in a safe and efficient manner, enabling them to advance its #glioblastoma (GBM) treatment and clinical pipeline as quickly as possible. https://t.co/PTBEcailqy #Vineti
In the last installment in our 4-part series on the current state of #cybersecurity in healthcare/life sciences, we're covering strategies for end users that will help them continuously assess, reassess, & evolve their cybersecurity practices: https://t.co/K4hBIb5zNi
Looking forward to @alliancerm's Cell & Gene Meeting on the Mesa in Oct.! This annual conference is an event the #Vineti team always looks forward to as it brings together top leaders in the industry to advance cutting-edge research. Learn more: https://t.co/p2K9D7Ft91